Pacific Biosciences of California, Inc. (PACB)

NASDAQ: PACB · Real-Time Price · USD

1.580

-0.130 (-7.60%)

At close: Feb 17, 2026, 4:00 PM EST

1.590

+0.010 (0.63%)

After-hours: Feb 17, 2026, 6:56 PM EST

PACB Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 17, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	477	565	539	2,624	1,850	4,513
Market Cap Growth	8.86%	4.82%	-79.47%	41.85%	-59.02%	-6.61%
Enterprise Value	909	969	988	2,792	1,964	4,387
Last Close Price	1.71	1.87	1.83	9.81	8.18	20.46
PS Ratio	3.21	3.53	3.50	13.08	14.42	34.58
PB Ratio	96.52	105.55	1.06	3.74	3.29	5.71
EV/Sales Ratio	5.68	6.06	6.42	13.93	15.30	33.61
Debt / Equity Ratio	131.32	131.32	1.33	1.33	1.69	1.21
Net Debt / Equity Ratio	79.06	79.06	0.56	0.43	0.31	-0.11
Net Debt / EBITDA Ratio	-8.03	-8.03	-1.13	-1.04	-0.60	0.52
Net Debt / FCF Ratio	-	-	-1.33	-1.13	-0.63	0.76
Asset Turnover	0.16	0.16	0.10	0.11	0.07	0.11
Inventory Turnover	1.95	1.95	1.84	2.66	2.00	3.68
Quick Ratio	5.79	5.79	6.30	7.03	3.00	14.90
Current Ratio	6.92	6.92	7.48	7.81	3.24	15.36
Return on Equity (ROE)	-213.45%	-213.45%	-51.30%	-48.53%	-46.42%	-32.17%
Return on Assets (ROA)	-34.09%	-34.09%	-12.08%	-11.04%	-10.10%	-9.20%
Return on Capital Employed (ROCE)	-76.40%	-76.40%	-24.30%	-18.80%	-20.30%	-9.20%
Earnings Yield	-112.41%	-96.78%	-57.53%	-11.69%	-16.99%	-4.01%
FCF Yield	-	-	-39.41%	-10.21%	-15.14%	-2.60%
Buyback Yield / Dilution	-9.28%	-9.28%	-8.22%	-12.95%	-10.00%	-16.67%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q